CAMBRIDGE, Mass., Feb. 29, 2012 /PRNewswire/ -- Idenix
Pharmaceuticals, Inc., (NASDAQ: IDIX) announced today that Idenix
management will present a corporate overview at the Cowen and
Company 32nd Annual Healthcare Conference on March 7, 2012 at 8:40 a.m.
ET at the Boston Marriott Copley Place, Massachusetts; the 24th Annual Roth Conference
on March 12, 2012 at 4:00 p.m. PT at the Ritz Carlton Laguna Niguel, California; and the Barclays
Capital Global Healthcare Conference on March 14, 2012 at 2:30
p.m. ET at the Loews Miami Hotel, Florida.
The live and archived webcasts of the company presentations can
be accessed under "Calendar of Events" in the Idenix Investor
Center at www.idenix.com. Please log in approximately 5-10 minutes
before each event to ensure a timely connection. The archived
replay will be available on the Idenix website for two weeks
following the conferences.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a
biopharmaceutical company engaged in the discovery and development
of drugs for the treatment of human viral diseases. Idenix's
current focus is on the treatment of patients with chronic
hepatitis C infection. For further information about Idenix, please
refer to http://www.idenix.com.
Idenix Pharmaceuticals Contacts:
Kelly Barry (617) 995-9033
(media)
Teri Dahlman (617) 995-9807
(investors)
SOURCE Idenix Pharmaceuticals, Inc.